Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001796536-26-000005
Filing Date
2026-05-27
Accepted
2026-05-27 17:26:06
Documents
1
Period of Report
2026-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1779917164.html 4  
1 FORM 4 wk-form4_1779917164.xml 4 4743
  Complete submission text file 0001796536-26-000005.txt   6431
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Business Address
Sanders Corazon (Corsee) D. (Reporting) CIK: 0001796536 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 261027652